Advancements in Intravesical Chemotherapy in Non-Muscle Invasive Bladder Cancer
The treatment for non-muscle-invasive bladder cancer is transurethral resection of bladder cancer followed by intravesical chemotherapy or BCG. There have been various advancements in low risk, intermediate risk, high risk, and BCG failure cases of non-muscle invasive bladder cancer. There has been...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/77926 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Advancements in Intravesical Chemotherapy in Non-Muscle Invasive Bladder Cancer
- Chemoprevention and Novel Treatments of Non-Muscle Invasive Bladder Cancer
- Perspective Chapter: Intravesical Chemohyperthermia with Mitomycin C in BCG-Unresponsive Nonmuscle-Invasive Bladder Cancer – Clinical Outcomes and Emerging Perspectives
- The Potential Role of Chemoprevention in the Management of Non-Muscle Invasive Bladder Urothelial Carcinoma
- Robot-Assisted Radical Cystectomy as a Treatment Modality for Patients with Muscle-Invasive Bladder Cancer
- Botulinum A Toxin Intravesical Injections in the Treatment of Refractory Overactive Bladder in Patients with Parkinson's Disease
- Reviewing AI's Role in Non-Muscle-Invasive Bladder Cancer Recurrence Prediction